Aktiesnakken — September 2013
-
Godt for zeal& at få en ny herrre i den stilling. og så fra Roche
Som jeg dog aldrig har hørt nævnt indenfor diabetes før? omend de har forsket i peptider mod kræft -
for fanden, havde troet mine nokia aktier skulle stå de næste mange år
-
jeg vidste at det blev microsoft!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind